Evaluation of Anti-Depressant Potential of Standardized Hydroethanolic Extract of S. barbata D. Don Using Chronic Unpredictable Mild Stress Model

Article ID: e26659786304405

  • * (Excluding Mailing and Handling)

Abstract

Background: S. barbata D. Don is a Chinese herb, that belongs to the family Lami-aceae. It has established traditional use in ethnomedicine for treating various ailments, includ-ing mood disorders and sleep disorders, which led to growing interest in exploring its neuro-logical potential, particularly as a potential anti-depressant agent.

Aims: This study explores the anti-depressant potential of the HSBE utilizing a Chronic Un-predictable Mild Stress-induced depression model in mice. Additionally, the research aims to elucidate the underlying mechanisms of action.

Methods: Swiss albino mice were subjected to a 3-week CUMS paradigm and subsequently administered HSBE at doses of 200 and 400 mg/kg via oral administration. The behavioral alterations were evaluated using the FST, TST, OFT, and SPT. Brain levels of serotonin, dopa-mine, and nor-epinephrine were estimated in different brain regions (cortex, hippocampus, and hypothalamus) to uncover the molecular mechanism. Additionally, assays for monoamine oxi-dase-A, monoamine oxidase-B, and antioxidant enzyme activities were conducted. Plasma ni-trite and corticosterone levels were also measured to get further insight into potential mecha-nisms underlying the anti-depressant effects of HSBE.

Results: HSBE significantly ameliorated depressive-like behavior induced by CUMS para-digm, as evidenced by reduced immobility in FST and TST, increased locomotor activity in OFT, and improved sucrose preference in SPT. Neurochemical analysis revealed a significant increase in serotonin, dopamine, and norepinephrine levels in the cortex, hippocampus, and hypothalamus of HSBE-treated mice, implying a potential regulation of monoaminergic neuro-transmitter levels. Moreover, biochemical analyses demonstrated a significant inhibition of both MAO-A and MAO-B activity, contributing to the increase of the brain levels of neuro-transmitters. The administration of HSBE also led to a significant enhancement of antioxidant enzyme activities and reduced brain lipid peroxidation, indicating a pronounced antioxidant effect of HSBE. Furthermore, decreased plasma nitrite and corticosterone levels provided ad-ditional insights into HSBE's potential multi-targeted anti-depressant mechanism.

Conclusion: This study indicates that HSBE exhibits robust anti-depressant properties, sup-ported by behavioral, neurochemical, and biochemical alterations. These findings underscore the therapeutic promise of HSBE as a natural intervention for depressive disorders, warranting further clinical exploration.

[1]
World Health Organization. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
[2]
Woody, C.A.; Ferrari, A.J.; Siskind, D.J.; Whiteford, H.A.; Harris, M.G. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J. Affect. Disord., 2017, 219, 86-92.
[http://dx.doi.org/10.1016/j.jad.2017.05.003] [PMID: 28531848]
[3]
Ferguson, J.M. SSRI antidepressant medications: Adverse effects and tolerability. Prim. Care Companion J. Clin. Psychiatry, 2001, 3(1), 22-27.
[PMID: 15014625]
[4]
Braund, T.A.; Tillman, G.; Palmer, D.M.; Gordon, E.; Rush, A.J.; Harris, A.W.F. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: An iSPOT-D report. Transl. Psychiatry, 2021, 11(1), 417.
[http://dx.doi.org/10.1038/s41398-021-01533-1] [PMID: 34349116]
[5]
Saha, K.; Torous, J.; Kiciman, E.; De Choudhury, M. Understanding side effects of antidepressants: Large-scale longitudinal study on social media data. JMIR Ment. Health, 2021, 8(3), e26589.
[http://dx.doi.org/10.2196/26589] [PMID: 33739296]
[6]
Chen, Q.; Rahman, K.; Wang, S.J.; Zhou, S.; Zhang, H. Scutellaria barbata: A review on chemical constituents, pharmacological activities and clinical applications. Curr. Pharm. Des., 2020, 26(1), 160-175.
[http://dx.doi.org/10.2174/1381612825666191216124310] [PMID: 31840605]
[7]
Wang, L.; Chen, W.; Li, M.; Zhang, F.; Chen, K.; Chen, W. A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don. J. Ethnopharmacol., 2020, 254, 112260.
[http://dx.doi.org/10.1016/j.jep.2019.112260] [PMID: 31577937]
[8]
Pannu, A.; Goyal, R.K. Pharmacognostical characterization of whole scutellaria barbata herb for quality control assessment. Innovat Int J Medical & Pharma Sci., 2021, 6(4), 1-5.
[9]
Pannu, A.; Goyal, R.K. Safety study of hydroethanol extract of scutellaria barbata d. Don in albino swiss mice as per OECD guidelines 425. Innovat Int J Medical & Pharma Sci., 2022, 7(2), 16-21.
[10]
Dhingra, D.; Bhankher, A. Behavioral and biochemical evidences for antidepressant-like activity of palmatine in mice subjected to chronic unpredictable mild stress. Pharmacol. Rep., 2014, 66(1), 1-9.
[http://dx.doi.org/10.1016/j.pharep.2013.06.001] [PMID: 24905299]
[11]
Dhingra, D.; Deepak, D. Antidepressant-like activity of flowers of Tecomella undulata in mice subjected to chronic unpredictable mild stress. Asian J. Pharm. Clin. Res., 2019, 12(1), 130-138.
[http://dx.doi.org/10.22159/ajpcr.2019.v12i1.28981]
[12]
Dhingra, D.; Valecha, R. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests. Med. Sci. Monit., 2007, 13(7), BR155-BR161.
[PMID: 17599020]
[13]
Charles, M.; McEwan, J. MAO activity in rabbit serum. In: Methods in enzymology; Academic Press: New York and London, 1977; XVIIB, pp. 692-698.
[14]
Schurr, A.; Livne, A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem. Pharmacol., 1976, 25(10), 1201-1203.
[http://dx.doi.org/10.1016/0006-2952(76)90369-5] [PMID: 938542]
[15]
Stahl, W.; Sies, H. β-Carotene and other carotenoids in protection from sunlight. Am. J. Clin. Nutr., 2012, 96(5), 1179S-1184S.
[http://dx.doi.org/10.3945/ajcn.112.034819] [PMID: 23053552]
[16]
Misra, H.P.; Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 1972, 247(10), 3170-3175.
[http://dx.doi.org/10.1016/S0021-9258(19)45228-9] [PMID: 4623845]
[17]
Aebi, H. Catalase in vitro. Methods Enzymol., 1984, 105, 121-126.
[http://dx.doi.org/10.1016/S0076-6879(84)05016-3] [PMID: 6727660]
[18]
Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95(2), 351-358.
[http://dx.doi.org/10.1016/0003-2697(79)90738-3] [PMID: 36810]
[19]
Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 1982, 126(1), 131-138.
[http://dx.doi.org/10.1016/0003-2697(82)90118-X] [PMID: 7181105]
[20]
Bartos, J.; Pesez, M. Colorimetric and fluorimetric determination of steroids. Pure Appl. Chem., 1979, 51(10), 2157-2169.
[http://dx.doi.org/10.1351/pac197951102157]
[21]
Cryan, J.F.; Markou, A.; Lucki, I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol. Sci., 2002, 23(5), 238-245.
[http://dx.doi.org/10.1016/S0165-6147(02)02017-5] [PMID: 12008002]
[22]
Detke, M.J.; Rickels, M.; Lucki, I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 1995, 121(1), 66-72.
[http://dx.doi.org/10.1007/BF02245592] [PMID: 8539342]
[23]
Hasler, G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry, 2010, 9(3), 155-161.
[http://dx.doi.org/10.1002/j.2051-5545.2010.tb00298.x] [PMID: 20975857]
[24]
Zakaria, F.H.; Samhani, I.; Mustafa, M.Z.; Shafin, N. Pathophysiology of depression: Stingless bee honey promising as an antidepressant. Molecules, 2022, 27(16), 5091.
[http://dx.doi.org/10.3390/molecules27165091] [PMID: 36014336]
[25]
Tian, H.; Hu, Z.; Xu, J.; Wang, C. The molecular pathophysiology of depression and the new therapeutics. MedComm, 2022, 3(3), e156.
[http://dx.doi.org/10.1002/mco2.156] [PMID: 35875370]
[26]
Katrenčíková, B.; Vaváková, M.; Paduchová, Z.; Nagyová, Z.; Garaiova, I.; Muchová, J.; Ďuračková, Z.; Trebatická, J. Oxidative stress markers and antioxidant enzymes in children and adolescents with depressive disorder and impact of omega-3 fatty acids in randomised clinical trial. Antioxidants, 2021, 10(8), 1256.
[http://dx.doi.org/10.3390/antiox10081256] [PMID: 34439504]
[27]
Varghese, F.P.; Brown, E.S. The hypothalamic-pituitary-adrenal axis in major depressive disorder: A brief primer for primary care physicians. Prim. Care Companion J. Clin. Psychiatry, 2001, 3(4), 151-155.
[PMID: 15014598]